The Impact of MACA Supplementation on Basketball-related Performance

NCT ID: NCT06243341

Last Updated: 2024-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this randomized crossover study, ten elite healthy male basketball players were included. Following a 17:00 PM training routine, participants completed a two-week supplementation with 2000 mg of MACA or placebo. After supplementation, participants underwent a Basketball Jump Shooting Accuracy Test and Repeated Sprint Ability Test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Supplementation with Lepidium meyenii (MACA) has been shown in animal studies to increase blood lactate clearance and rapid lactate removal, which may be effective in reducing fatigue during intermittent exercise. However, no studies have investigated the effects of MACA supplementation on interval exercise and basketball performance. We hypothesized that MACA supplementation could reduce fatigue and improve performance in elite healthy male basketball players. This study aimed to determine the effectiveness of MACA compared to placebo on overall basketball performance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sports

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

a double blind crossover study
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators
a double blind crossover study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MACA (MC)

Daily MACA supplementation for two weeks.

Group Type EXPERIMENTAL

Lepidium meyenii (MACA)

Intervention Type DIETARY_SUPPLEMENT

The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.

placebo

Daily placebo supplementation for two weeks.

Group Type PLACEBO_COMPARATOR

Lepidium meyenii (MACA)

Intervention Type DIETARY_SUPPLEMENT

The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lepidium meyenii (MACA)

The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

100% corn-starch maltodextrin powder

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (i) healthy male adults, those individuals who are free of pain, insomnia, or other injuries recently, without any medication used in recent 2 months,
* (ii) basketball players competing in a Taiwan university basketball association for more than two years.

Exclusion Criteria

* (i) were below 20 years old,
* (ii) did not have won at least eighth place in national-level basketball competitions,
* (iii) were with cardiovascular diseases or any disease that made subjects feel ill.
Minimum Eligible Age

20 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan Sport University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chih-Hui Chiu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Che-Hsiu Chen, PhD

Role: STUDY_DIRECTOR

Sport Science Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University of Sport

Taichung, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Stone M, Ibarra A, Roller M, Zangara A, Stevenson E. A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. J Ethnopharmacol. 2009 Dec 10;126(3):574-6. doi: 10.1016/j.jep.2009.09.012. Epub 2009 Sep 23.

Reference Type RESULT
PMID: 19781622 (View on PubMed)

Wu PS, Wu SH, Jiang RS, Chen CH, Chen BW, Chiu CH. The Impact of Lepidium meyenii (MACA) Supplementation on Basketball-related Performance and Antifatigue Ability: A Double-blind Crossover Study. J Physiol Investig. 2025 Sep 1;68(5):297-304. doi: 10.4103/ejpi.EJPI-D-25-00037. Epub 2025 Sep 17.

Reference Type DERIVED
PMID: 40960048 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

113-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.